Cheapest way to buy Brooklyn ImmunoTherapeutics shares in the UK

BlackRock Technology and Private Equity Term Trust (BTX) is a publicly traded asset management business based in the US. Brooklyn ImmunoTherapeutics is listed on the NYSE and traded in US dollars. Its current price of $6.96 is 11.3% up on its price a month ago ($6.25).

How to buy shares in Brooklyn ImmunoTherapeutics

Open a brokerage account. Choose from our top broker picks or compare brokers in depth. To trade US shares you'll need to complete a W8-BEN form – typically part of the sign-up process.
Fund your account. Add money to your account via bank transfer or debit card.
Search the platform by ticker symbol. BTX in this case.
Choose an order type. Place a market order (or limit order, if you want to try to hold out for a specific price) with your preferred number of shares or investment amount.
Submit the order. It's that simple.

The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Our top picks for where to buy Brooklyn ImmunoTherapeutics shares

Best for 0% commission stocks

Finder Award

Go to site

Capital at risk. T&Cs apply.

Copy picks from top traders

Commission-free trades
Fractional shares
Get dividend payments

Best for uninvested cash

Go to site

Capital at risk. T&Cs apply.

Up to 4.25% interest on uninvested cash

11,000+ stocks & ETFs
Commission-free investing
Advanced trading tools

Best for fractional shares

Go to site

Capital at risk. T&Cs apply.

Earn 4.5% on uninvested funds

Commission-free trades
Fractional shares
5,400+ stocks/ETFs

We analysed all popular share dealing platforms in the UK using 35 data points and combined this with our expert insight from using the apps. The platforms we've selected as best for each category offer stand-out features or a unique combination of elements for a specific aspect of investing. If we show a "Promoted for" pick, it's been chosen from among our partners and is based on factors that include special features or offers, and the commission we receive. Keep in mind that our picks may not always be the best for you – it's important to compare for yourself. More details in our full methodology.

Brooklyn ImmunoTherapeutics stock chart

Use our graph to track the performance of BTX stock over time.

Fees calculator for buying Brooklyn ImmunoTherapeutics shares with popular apps

Find the cheapest way to buy Brooklyn ImmunoTherapeutics shares with our calculator. Bear in mind that both exchange rates and share prices fluctuate in real time, so the costs estimated here are just a guide (refer to platforms themselves for availability and exact pricing).

Quantity of shares

100

Finder Score	Account fee	Min. initial deposit	Trade cost	Link
9 Excellent	£0	$100	£525.07	Go to siteCapital at risk
9.1 Excellent	£0	£0	£526.32	Go to siteCapital at risk
9 Excellent	From £0	£0	£524.81	Go to siteCapital at risk
8.8 Great	£0	£0	£521.32	Go to siteCapital at risk
9.2 Excellent	£0	£0	£523.77	Go to siteCapital at risk
8.5 Great	£0 (0.45% for funds)	£1	£538.33	Go to siteCapital at risk

Full comparison of share dealing platforms

These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy Brooklyn ImmunoTherapeutics stock?

Review technicals and fundamentals to help you determine if now's a good time for you to invest.

Technical analysis

View Brooklyn ImmunoTherapeutics's price performance, share price volatility, historical data and technicals.

Quick verdict
Historical data

The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Historical closes compared with the last close of $6.9631

1 week (2025-05-23)	3.93%
1 month (2025-04-30)	11.34%
3 months (2025-03-02)	-1.82%
6 months (2024-11-30)	-12.85%
1 year (2024-05-30)	-5.52%
2 years (2023-05-30)	-6.91%
3 years (2022-05-30)	-96.09%
5 years (2020-05-30)	-62.15%

Invest in Brooklyn ImmunoTherapeutics shares

Finder AwardFree Trades

Over 5,500+ stocks from 20 exchanges
Free to open an account
Commission-free trading

Go to site

Capital at risk

Is Brooklyn ImmunoTherapeutics under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Brooklyn ImmunoTherapeutics P/E ratio, PEG ratio and EBITDA.

P/E ratio

Brooklyn ImmunoTherapeutics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 41x. In other words, Brooklyn ImmunoTherapeutics's shares trade at around 41x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of March 2025 (25.37). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Frequently asked questions

- Dividend yield
- Forward yield
Dividend yield: 14.24% of stock value
Forward annual dividend yield: 14.24% of stock value

Brooklyn ImmunoTherapeutics has recently paid out dividends equivalent to 14.24% of its share value annually.

Brooklyn ImmunoTherapeutics has paid out, on average, around 490.53% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 14.24% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 14.24% return on their shares, in the form of dividend payments.

Brooklyn ImmunoTherapeutics's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

Brooklyn ImmunoTherapeutics's most recent dividend payout was on 29 May 2025. To be eligible for the latest dividend you would need to have been a shareholder at 14 May 2025 (the "ex-dividend date").
Brooklyn ImmunoTherapeutics's shares were split on a 1:20 basis on 16 October 2022. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Brooklyn ImmunoTherapeutics shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Brooklyn ImmunoTherapeutics shares which in turn could have impacted Brooklyn ImmunoTherapeutics's share price.
It's as easy to sell Brooklyn ImmunoTherapeutics as it is to buy! Here's how to sell Brooklyn ImmunoTherapeutics shares that you already own.
1. Open your investment app. If you've got one with desktop access, you can log in online
2. Go to your portfolio. This should be in the main menu
3. Find your shares. You may be able to search your portfolio
4. Choose how many you'd like to sell. You'll be able to review the price and see how much you'll receive
5. Sell your Brooklyn ImmunoTherapeutics shares. Your investment platform will let you know when your shares are sold
The easiest way to get hold of some Brooklyn ImmunoTherapeutics shares is to sign up for a share trading app and place a market order or basic order. This type of order tells the platform that you're interested, so it'll try to execute it as quickly as it can. It could take some time for the order to go through, especially if there's a lot of volatility in Brooklyn ImmunoTherapeutics shares.

Gross profit TTM	$0
Return on assets TTM	-35.3%
Return on equity TTM	-427.17%
Profit margin	0%
Book value	$0.26
Market capitalisation	$1.4 billion

Thank you for your feedback!

More resources on Finder

How to buy Scienjoy Holding shares How to buy Infinite Ore shares

More guides on Finder

Best stock brokers in the UK
Search our directory of UK stock brokers partnered with the London Stock Exchange (LSE) and learn about how each of them operates.
InvestEngine promo codes for 2025
See if you can make your investment go even further with free-share, cashback or refer-a-friend offers from InvestEngine. Here’s what’s live right now.
Lightyear promo codes for 2025
See if you can make your money go further with free-share, cashback or refer-a-friend offers from Lightyear. Here’s what’s live right now.
Trading 212 promo codes for 2025
See if you can make your money go further with free-share, cashback or refer-a-friend offers from Trading 212. Here’s what’s live right now.
Best investment platforms paying high interest on cash
Some trading apps and platforms now offer competitive interest rates on uninvested cash.
Best trading apps in the UK (2025)
We’ve tested, analysed and scored trading apps to find the 10 best trading apps in the UK, who they’re best for and the pros and cons.
Best trading apps for beginners
We’ve reviewed the best online trading platforms in the UK and explained why they’re best suited to beginners, with pros and cons.
Best junior stocks and shares ISAs
A junior stocks and shares ISA account (JISA) is a tax-efficient way to save for your child’s future, here are the best options and how to compare.
Best stocks and shares ISA in the UK for 2025
We’ve reviewed the best stocks and shares ISA accounts in the UK, explaining who they might suit and what the benefits and drawbacks are.
Best investment trusts for 2025
We’ve put together a list of the best investment trusts of recent times, in terms of performance, income generation and popularity.

How to buy Brooklyn ImmunoTherapeutics shares

Easy steps to invest in Brooklyn ImmunoTherapeutics stock in the UK.

How to buy shares in Brooklyn ImmunoTherapeutics